| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of General Virology, Vol 78, 619-625, Copyright © 1997 by Society for General Microbiology
ARTICLES |
K Fujita, S Omura and J Silver
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Human immunodeficiency virus (HIV) type 1 encodes three genes, Vpu, Env and Nef, that decrease cellular CD4. Vpu and Env act cooperatively to accelerate degradation of CD4 in the endoplasmic reticulum. Here we report that Vpu/Env-induced CD4 degradation is inhibited by lactacystin, a specific inhibitor of the proteasome, and by other proteasome inhibitors, but not by non-proteasome protease inhibitors. We also note that Vpu has amino acid sequence homology with a segment of IkappaB known to be involved in proteasome-mediated degradation, suggesting that HIV-1 could have transduced cellular sequences to enhance down-regulation of CD4.
This article has been cited by other articles:
|
|
 |
|
  A. Hussain, C. Wesley, M. Khalid, A. Chaudhry, and S. Jameel Human Immunodeficiency Virus Type 1 Vpu Protein Interacts with CD74 and Modulates Major Histocompatibility Complex Class II Presentation J. Virol., January 15, 2008; 82(2): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Richards and P. R. Clapham Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages J. Gen. Virol., October 1, 2007; 88(10): 2780 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Hebert and M. Molinari In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases Physiol Rev, October 1, 2007; 87(4): 1377 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Biragyn, P. A. Ruffini, M. Coscia, L. K. Harvey, S. S. Neelapu, S. Baskar, J.-M. Wang, and L. W. Kwak Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo Blood, October 1, 2004; 104(7): 1961 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ros, C. J. Burckhardt, and C. Kempf Cytoplasmic Trafficking of Minute Virus of Mice: Low-pH Requirement, Routing to Late Endosomes, and Proteasome Interaction J. Virol., November 13, 2002; 76(24): 12634 - 12645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Z. Fernandis, R. P. Cherla, R. D. Chernock, and R. K. Ganju CXCR4/CCR5 Down-modulation and Chemotaxis Are Regulated by the Proteasome Pathway J. Biol. Chem., May 10, 2002; 277(20): 18111 - 18117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Luo, B. L. Fredericksen, K. Hasumi, A. Endo, and J. V. Garcia Human Immunodeficiency Virus Type 1 Nef-Induced CD4 Cell Surface Downregulation Is Inhibited by Ikarugamycin J. Virol., March 1, 2001; 75(5): 2488 - 2492. [Abstract] [Full Text]
|
|
|
|
|
|
S. Gummuluru, C. M. Kinsey, and M. Emerman An In Vitro Rapid-Turnover Assay for Human Immunodeficiency Virus Type 1 Replication Selects for Cell-to-Cell Spread of Virus J. Virol., December 1, 2000; 74(23): 10882 - 10891. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. W. Doms and D. Trono The plasma membrane as a combat zone in the HIV battlefield Genes & Dev., November 1, 2000; 14(21): 2677 - 2688. [Full Text]
|
|
|
|
|
|
C. Reichel and R. N. Beachy Degradation of Tobacco Mosaic Virus Movement Protein by the 26S Proteasome J. Virol., April 1, 2000; 74(7): 3330 - 3337. [Abstract] [Full Text]
|
|
|
|
|
|
T. Maniatis A ubiquitin ligase complex essential for the NF-kappa B, Wnt/Wingless, and Hedgehog signaling pathways Genes & Dev., March 1, 1999; 13(5): 505 - 510. [Full Text]
|
|
|
|
|
|
U. Schubert, S. Bour, R. L. Willey, and K. Strebel Regulation of Virus Release by the Macrophage-Tropic Human Immunodeficiency Virus Type 1 AD8 Isolate Is Redundant and Can Be Controlled by either Vpu or Env J. Virol., February 1, 1999; 73(2): 887 - 896. [Abstract] [Full Text]
|
|
|
|
|
|
C. R. Casella, E. L. Rapaport, and T. H. Finkel Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing J. Virol., January 1, 1999; 73(1): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schubert, L. C. Anton, J. H. Cox, S. Bour, J. R. Bennink, M. Orlowski, K. Strebel, and J. W. Yewdell CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway J. Virol., March 1, 1998; 72(3): 2280 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bour, C. Perrin, H. Akari, and K. Strebel The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B J. Biol. Chem., May 4, 2001; 276(19): 15920 - 15928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Furman, H. L. Ploegh, and D. Tortorella Membrane-specific, Host-derived Factors Are Required for US2- and US11-mediated Degradation of Major Histocompatibility Complex Class I Molecules J. Biol. Chem., January 25, 2002; 277(5): 3258 - 3267. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
